Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Yellow helicopter with three people with appeal signs
    21 April 2026

    East Anglian Air Ambulance launches £8.2m appeal to build new Cambridge base

    Former patients help charity launch appeal as it calls on people and businesses across Cambridgeshire to help protect the future of their local air ambulance. ...

    storm logo
    20 April 2026

    STORM Therapeutics secures $56 million series C financing and doses first patient in phase 2 Sarcoma Trial of STC‑15

    The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms malignant progenitor cells by modulating mRNA methylation16 April 2026, Cambridge, UK: STORM Therapeutics Ltd., the clinical stage company targe...

    STORganoid™ ambient-temperature preservation solution for organoids and spheroids
    21 April 2026

    Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models

    Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies  ...

    Medical device manufacturing scale-up in Cambridge
    20 April 2026

    Bridging Cambridge’s MedTech scale-up gap: the missing link between prototype and production

    Cambridge leads in early-stage MedTech innovation, but many promising ideas stall when moving from lab prototypes to clinical-ready devices. The core challenge lies in fragmented, early-stage manufacturing and regulatory pathways, often pushing companies to look overseas. This reflects ...

    the 93rd China International Medical Equipment Fair (CMEF) at Shanghai
    17 April 2026

    One show, two industries: What CMEF 93 revealed about Chinese medTech

    The 93rd China International Medical Equipment Fair (CMEF) in Shanghai looked the same on paper as previous years — 320,000 sqm, 5,000 exhibitors, 300,000 visitors — but four days on the floor revealed a structurally divided market. NPZ Technology shares observations that matter for UK ...

    Ophthalmic drug delivery
    16 April 2026

    The retinal delivery bottleneck: why today’s tools won’t scale

    Cell and gene therapies make up a large and growing proportion of pipeline treatments for high-prevalence diseases of the retina. For these advanced therapies to deliver on their promise, most need to be delivered into the retina, overcoming significant physiological barriers. But exist...

    London Marathon runner Jack Sibbons with his twin sister, Amy De Silva, her husband Greg, and their children, Hugo, Dawson and Chester, with Amy and Jack's mum, Sally
    15 April 2026

    'Addenbrooke's saved my twin sister - and her baby': the powerful stories inspiring Addenbrooke’s Charitable Trust’s TCS London Marathon runners

    Addenbrooke's Charitable Trust (ACT) has a record 18 runners in this year's TCS London Marathon. Not only that - but to date they have also raised a record £54,000 between them. To hear their stories, and to find out why they are running to raise funds for Addenbrooke's and the Rosie, s...

    Illustration of a professional using a laptop with a large clock, representing 90-minute Microsoft Copilot training for busy teams
    15 April 2026

    Supporting busy teams with practical 90-minute Microsoft Copilot training

    Help your team save time, reduce manual work, and get more from Microsoft Copilot. These 90-minute, instructor-led sessions focus on practical skills your team can start using immediately in Excel, Word and PowerPoint. ...

    Atelerix
    15 April 2026

    Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

    Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the regionExpands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and research collaborationsS...

    logo
    14 April 2026

    Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform

    ·       Proceeds will help enhance workflows and expand single-cell functional assay portfolio·       Brad Crutchfield joins as advisor to support early access growth and  global launch ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 23
    • Page 24
    • Current page 25
    • Page 26
    • Page 27
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS